AT-406 (SM-406): Reliable Apoptosis Assays
2026-08-14
A scenario-based guide to using AT-406 (SM-406), SKU A3019, for apoptosis, viability, and chemosensitization studies. It connects target engagement, solvent handling, dose selection, orthogonal readouts, and vendor evaluation to documented product data and apoptosis literature.
Dabigatran: From Thrombin Mechanism to Translation
2026-08-13
Dabigatran is more than a potent direct thrombin inhibitor: it is a translational tool for connecting molecular thrombin biology with plasma coagulation, therapeutic strategy, and assay design. This article outlines how to use Dabigatran and its metabolite benchmarks rigorously while avoiding common errors involving formulation, species translation, renal function, and clinical-to-laboratory extrapolation.
SAN-Plexus Assembloids Model Pacemaker Maturation
2026-08-13
This study introduces human pluripotent stem cell-derived SAN-plexus assembloids that combine sinoatrial node, cardiac ganglionated plexus, and atrial-like organoids to model neuro-pacemaker development. By integrating electrophysiology with human SAN spatial transcriptomics, the authors identify a CGPO-derived prosaposin–GPR37 signaling axis that promotes pacemaker maturation and provides a framework for studying conduction dysfunction.
Mitochondrial Calcium Signaling and Ferroptosis
2026-08-12
The reference study links mitochondrial calcium uptake through MCU to ferroptosis control by sustaining acetyl-CoA-dependent acetylation and activity of GPX4. Genetic, antioxidant-rescue, structural, and tumor-model experiments identify a mechanistic connection between mitochondrial metabolism, GPX4 regulation, and cancer-cell survival.
Cefodizime BA1050: Workflow and Resistance Insights
2026-08-12
Cefodizime BA1050 supports reproducible antibacterial assays, resistance surveillance, and infection-model workflows. This guide connects its PBP-directed activity with practical stock preparation, MIC testing, immune-cell controls, and hospital-derived antimicrobial stewardship insights.
MLN2238: Proteasome β5 Inhibitor Workflow
2026-08-11
MLN2238 enables controlled chymotrypsin-like proteasome inhibition for apoptosis, proteotoxic-stress, multiple myeloma, and lymphoma research. This practical guide combines dose–response design, reversible-exposure workflows, resistance studies, and ROS/JNK/CREB readouts inspired by a key Drosophila and 293T study.
ETS1–SENP2–HSPA8–FUNDC1 Axis in BPD
2026-08-10
The reference study identifies ETS1 as a transcriptional regulator that protects against hyperoxia-induced bronchopulmonary dysplasia by controlling the SENP2/HSPA8/FUNDC1 mitophagy axis. Its findings connect FUNDC1 SUMO1 de modification, HSPA8 binding, and mitochondrial quality control, while also defining important limits for translating this mechanism beyond experimental BPD models.
Diethylmaleate Workflows for Redox Research
2026-08-09
Build controlled glutathione-depletion experiments with Diethylmaleate for oxidative stress, GST, and pesticide-resistance studies. This practical guide connects stock preparation, assay controls, and troubleshooting to findings from a Megalurothrips usitatus resistance model.
Bromodomain Inhibitor (+)-JQ1: Applied Workflows
2026-08-08
Bromodomain Inhibitor, (+)-JQ1 enables mechanism-led studies of BRD4, apoptosis, EMT, inflammation, and BRDT biology. This practical guide translates BET inhibition into dose planning, combination assays, pathway readouts, and troubleshooting strategies.
Trichostatin A: From Chromatin to Translation
2026-08-07
Trichostatin A (TSA) is more than a laboratory HDAC inhibitor: it is a reversible chromatin perturbation tool that can connect histone acetylation, differentiation, cell-cycle control, and combination treatment design. This article examines how TSA supports epigenetic regulation in cancer research, interprets evidence from a pancreatic ductal adenocarcinoma screen, and outlines a disciplined path from cell assays to in vivo validation.
Double-Positive Feedback Between AMPK and SQSTM1 in Metaboli
2026-08-07
This study reveals a novel double-positive feedback loop between AMPK and SQSTM1/p62 during metabolic stress, leading to the dual activation of AMPK and NFE2L2/NRF2 and enhancing antioxidant defenses. These findings advance our understanding of tumor adaptation mechanisms and suggest new avenues for targeting metabolic vulnerabilities in cancer.
Bismuth Subsalicylate: Precision Modulation of GI Membrane D
2026-08-06
Explore how Bismuth Subsalicylate enables precise study of gastrointestinal membrane dynamics, bridging inflammation pathway modulation and advanced apoptosis detection. This article offers a unique, mechanism-focused analysis distinct from existing content.
KPT-330 (Selinexor): Redefining Nuclear Export in Cancer Res
2026-08-06
Explore how KPT-330 (Selinexor) is revolutionizing translational cancer research by targeting nuclear export via CRM1 inhibition. This thought-leadership article blends mechanistic insight, evidence-based strategy, and actionable guidance for researchers seeking to overcome chemoresistance and drive new therapeutic frontiers.
Suhuang Capsule Inhibits ER Stress and NLRP3 in Cough Varian
2026-08-05
The reference study reveals how Suhuang antitussive capsule ameliorates pulmonary dysfunction in cough variant asthma by suppressing endoplasmic reticulum (ER) stress and inhibiting NLRP3 inflammasome activation. These mechanistic insights clarify the connection between ER stress modulation and airway inflammation, supporting more targeted approaches to respiratory disease intervention.
QX77 Molecular Chaperone Activator: Protocols & Advanced Use
2026-08-05
QX77 enables targeted upregulation of LAMP2A and Rab11, uniquely empowering researchers to dissect chaperone-mediated autophagy and drive stem cell differentiation. This guide translates the latest mechanistic insights and practical protocols into actionable strategies for autophagy pathway modulation and troubleshooting in advanced cellular research.
466 records 9/32 page Previous Next First page 上5页 678910 下5页 Last page